ChromoHub V2: Cancer genomics

Bioinformatics

Volumn 30, Issue 4, 2014, Pages 590-592

  Shah, Muhammad A ^a   Denton, Emily L ^a   Liu, Lihua ^a   Schapira, Matthieu ^a,b  

^a Structural Genomics Consortium   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE;

ARTICLE; CHROMATIN; COMPUTER PROGRAM; DNA METHYLATION; GENE EXPRESSION PROFILING; GENETIC EPIGENESIS; GENETICS; GENOMICS; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN GENOME; MUTATION; NEOPLASM; PROMOTER REGION;

CHROMATIN; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENOME, HUMAN; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HISTONES; HUMANS; MUTATION; NEOPLASMS; PROMOTER REGIONS, GENETIC; SOFTWARE;

EID: 84894537386     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btt710     Document Type: Article

References (21)

1. Baylin, S.B. and Jones, P.A. (2011) A decade of exploring the cancer epigenome-biological and translational implications. Nat. Rev. Cancer, 11, 726-734.
2. Beroukhim, R. et al. (2007) Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc. Natl Acad. Sci. U. S. A., 104, 20007-20012.
3. Biankin, A.V. et al. (2012) Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature, 491, 399-405.
4. Dalgliesh, G.L. et al. (2010) Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature, 463, 360-363.
5. Eifert, C. and Powers, R.S. (2012) From cancer genomes to oncogenic drivers, tumour dependencies and therapeutic targets. Nat. Rev. Cancer, 12, 572-578.
6. Ellis, M.J. et al. (2012) Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature, 486, 353-360.
7. Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of cancer: the next generation. Cell, 144, 646-674.
8. Ho, A.S. et al. (2013) The mutational landscape of adenoid cystic carcinoma. Nat. Genet., 45, 791-798.
9. Jones, D.T. et al. (2012) Dissecting the genomic complexity underlying medulloblastoma. Nature, 488, 100-105.
10. Le Gallo, M. et al. (2012) Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes. Nat. Genet., 44, 1310-1315.
11. Liu, L. et al. (2012) ChromoHub: a data hub for navigators of chromatin-mediated signalling. Bioinformatics, 28, 2205-2206.
12. Mermel, C.H. et al. (2011) GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol., 12, R41.
13. Morin, R.D. et al. (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature, 476, 298-303.
14. Pugh, T.J. et al. (2012) Medulloblastoma exome sequencing uncovers subtypespecific somatic mutations. Nature, 488, 106-110.
15. Robinson, G. et al. (2012) Novel mutations target distinct subgroups of medulloblastoma. Nature, 488, 43-48.
16. Schwartzentruber, J. et al. (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature, 482, 226-231.
17. Stephens, P.J. et al. (2012) The landscape of cancer genes and mutational processes in breast cancer. Nature, 486, 400-404.
18. Timp, W. and Feinberg, A.P. (2013) Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host. Nat. Rev. Cancer, 13, 497-510.
19. Varela, I. et al. (2011) Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature, 469, 539-542.
20. You, J.S. and Jones, P.A. (2012) Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell, 22, 9-20.
21. Zhang, J. et al. (2012) The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature, 481, 157-163.